Showing results (1671-1680 of 1,753) with videos related to
Sort By:
Pageof 176
Critical Care Medicine|December 19, 2017
Endotype Transitions During the Acute Phase of Pediatric Septic Shock Reflect Changing Risk and Treatment ResponseHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.Frontiers in Immunology|May 30, 2019
Evaluation of Mannose Binding Lectin Gene Variants in Pediatric Influenza Virus-Related Critical IllnessEmily R Levy, Wai-Ki Yip, Michael Super, et al.Nature|October 31, 2024
Tissue spaces are reservoirs of antigenic diversity for Trypanosoma bruceiAlexander K Beaver, Zhibek Keneskhanova, Raúl O Cosentino, et al.Critical Care Medicine|June 9, 2016
Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to CorticosteroidsHector R Wong, Sarah J Atkinson, Natalie Z Cvijanovich, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|August 8, 2024
Diagnostic Validation of the Updated Pediatric Sepsis Biomarker Risk II for Acute Kidney Injury Prediction Model in Pediatric Septic ShockNatalja L Stanski, Bin Zhang, Natalie Z Cvijanovich, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 3, 2018
Hyperchloremia Is Associated With Complicated Course and Mortality in Pediatric Patients With Septic ShockErin K Stenson, Natalie Z Cvijanovich, Nick Anas, et al.Critical Care Medicine|October 23, 2013
Post-ICU admission fluid balance and pediatric septic shock outcomes: a risk-stratified analysisKamal Abulebda, Natalie Z Cvijanovich, Neal J Thomas, et al.The Journal of Clinical Endocrinology and Metabolism|February 25, 2026
Age-Specific Risk of Malignancy in Pediatric Thyroid Cytology: Reframing ROM based on pre-test probabilitySule Canberk, Zubair W Baloch, Amber Isaza, et al.Journal of Cancer Research and Clinical Oncology|July 25, 2023
Early clinical trial unit tumor board: a real-world experience in a national cancer networkL Weiss, K Dorman, M Boukovala, et al.ESMO Open|March 27, 2026
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort studyF Moik, F Huemer, B Doleschal, et al.Pageof 176